SignatureFD
CLSD icon

SignatureFD’s Clearside Biomedical CLSD Stock Holding History

SignatureFD’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,612
Closed -$47.1K – 3153
2023
Q3 		$47.1K Hold
3,612
– – ﹤0.01% 1416
2023
Q2 		$60.7K Hold
3,612
– – ﹤0.01% 1322
2023
Q1 		$56.3K Hold
3,612
– – ﹤0.01% 1331
2022
Q4 		$60.7K Hold
3,612
– – ﹤0.01% 1262
2022
Q3 		$61K Hold
3,612
– – ﹤0.01% 1181
2022
Q2 		$80K Hold
3,612
– – ﹤0.01% 1075
2022
Q1 		$124K Hold
3,612
– – ﹤0.01% 939
2021
Q4 		$149K Sell
3,612
-19
-0.5% -$1.23K ﹤0.01% 838
2021
Q3 		$327K Buy
3,631
+19
+0.5% +$1.68K 0.01% 505
2021
Q2 		$264K Hold
3,612
– – 0.01% 554
2021
Q1 		$134K Hold
3,612
– – 0.01% 750
2020
Q4 		$148K Sell
3,612
-4,368
-55% -$113K 0.01% 636
2020
Q3 		$184K Sell
7,980
-110
-1% -$2.84K 0.01% 509
2020
Q2 		$228K Sell
8,090
-42
-0.5% -$1.24K 0.01% 408
2020
Q1 		$207K Buy
8,132
+4,244
+109% +$157K 0.02% 403
2019
Q4 		$169K Sell
3,888
-8,378
-68% -$176K 0.01% 520
2019
Q3 		$116K Hold
12,266
– – 0.01% 593
2019
Q2 		$179K Hold
12,266
– – 0.02% 428
2019
Q1 		$254K Hold
12,266
– – 0.02% 320
2018
Q4 		$197K Buy
12,266
+8,378
+215% +$393K 0.02% 362
2018
Q3 		$359K Buy
3,888
+3,427
+743% +$407K 0.04% 266
2018
Q2 		$74K Buy
+461
New +$77.7K 0.01% 715

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Carmignac Gestion
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SignatureFD's CLSD Position: Q4 2023 in Review

SignatureFD sold out of Clearside Biomedical (CLSD) in Q4 2023, closing a stake of 3,612 shares — an estimated $47.1K sold.

SignatureFD first reported a position in CLSD in Q2 2018 and held it in 22 quarters. The position peaked at $359K in Q3 2018. 46 funds tracked by Wall St. Rank hold CLSD as of Q4 2023.

  • SignatureFD reported no remaining Clearside Biomedical position as of Q4 2023 after selling out during the quarter.
  • SignatureFD sold 3,612 Clearside Biomedical shares in Q4 2023, an estimated $47.1K.
  • SignatureFD first reported a position in Clearside Biomedical in Q2 2018 and held it in 22 quarters.
  • SignatureFD's Clearside Biomedical position peaked at $359K in Q3 2018.
  • 46 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2023.

Based on SignatureFD's 13F filing for Q4 2023, filed 1 Feb 2024.